NCT01310361

Brief Summary

In some studies once daily amoxicillin therapy might be treatment of choice for Group A β-hemolytic Streptococcus pharyngitis in comparison with three to four times daily treatment with oral penicillin V.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2004

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

March 7, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 8, 2011

Completed
Last Updated

March 8, 2011

Status Verified

January 1, 2005

First QC Date

March 7, 2011

Last Update Submit

March 7, 2011

Conditions

Keywords

PharyngitisGroup A β-hemolytic StreptococciExudateErythema PenicillinAmoxicillin

Study Arms (2)

Amoxicillin

EXPERIMENTAL

Once-daily Therapy for Streptococcal Pharyngitis With Amoxicillin

Drug: Amoxicillin

Benzathin Penicillin G

ACTIVE COMPARATOR

Once-daily Therapy for Streptococcal Pharyngitis With Intramuscular Benzathin Penicillin G

Drug: Intramuscular Benzathin Penicillin G

Interventions

Amoxicillin

It is mentioned underlined in page 10 in research. (Once the throat swab was taken and cultured on plate at the place where the child was examined, hygiene teacher was trained about how to prepare the oral amoxicillin suspension and how to give it to the child. 750 milligrams of amoxicillin was thereafter given to the patient and in order not to infect other school children, the patient was sent home. The following morning, the patient would come to school and was given the second dose of amoxicillin by the hygiene teacher. All oral drugs were bought from a creditable company. In the injection group, 600000 units of penicillin was administered to children who weigh less than 27 kilograms and 1200000 units of penicillin was administered to children who weigh more. After 48 hours, patients were examined again when the result of first culture was ready)

Benzathin Penicillin G

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Age GroupsChild (0-17)

You may qualify if:

  • Age of 6 to 15 years old.
  • The criteria in clinical examination including objective signs (fever, Erythema or exudate of tonsils, enlarged lymph nodes) and subjective sign(sore throat). Neck tenderness, abdominal pain and pharynx petechia were also considered.
  • No antibiotic was used during the week before.
  • Performing throat culture before the initiation of drug administration
  • Positive throat culture indication GABHS
  • No previous history of allergy to penicillin .

You may not qualify if:

  • Age of below 6 years old or above 15 years old.
  • No signs of pharyngitis in the clinical examination
  • Antibiotic use during the week before.
  • Throat culture was not performed before the initiation of drug administration.
  • Negative throat culture or the culture indicates a microorganism other than GABHS.
  • History of allergy to penicillin
  • Not using drugs or not following the treatment in the field of having the second culture performed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Islamic Azad University

Mashhad, Khorasan, 91796, Iran

Location

MeSH Terms

Conditions

Pharyngitis

Interventions

Amoxicillin

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

AmpicillinPenicillin GPenicillinsbeta-LactamsLactamsAmidesOrganic ChemicalsSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 7, 2011

First Posted

March 8, 2011

Study Start

January 1, 2004

Study Completion

March 1, 2006

Last Updated

March 8, 2011

Record last verified: 2005-01

Locations